SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-049457
Filing Date
2021-09-23
Accepted
2021-09-23 07:05:43
Documents
14
Period of Report
2021-09-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea147836-8k_cleneinc.htm   iXBRL 8-K 29987
2 PRESS RELEASE DATED SEPTEMBER 23, 2021 ANNOUNCING INITIATION OF A SECOND FDA EXP ea147836ex99-1_clene.htm EX-99.1 16009
  Complete submission text file 0001213900-21-049457.txt   276234

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE clnn-20210923.xsd EX-101.SCH 3815
4 XBRL DEFINITION FILE clnn-20210923_def.xml EX-101.DEF 27812
5 XBRL LABEL FILE clnn-20210923_lab.xml EX-101.LAB 36982
6 XBRL PRESENTATION FILE clnn-20210923_pre.xml EX-101.PRE 26430
7 EXTRACTED XBRL INSTANCE DOCUMENT ea147836-8k_cleneinc_htm.xml XML 5735
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 211271006
SIC: 2834 Pharmaceutical Preparations